Related Experiment Video
Updated: Oct 18, 2025

Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
Published on: August 3, 2021
"You're on mute!" Does pediatric CF home spirometry require physiologist supervision?
Emma Fettes1, Mollie Riley1, Stephanie Brotherston1
1Lung Function Laboratory, Great Ormond Street Hospital for Children, HNS Foundation Trust, London, UK.
Insights
Remote supervision of home spirometry in children with cystic fibrosis significantly improves test quality. While supervised tests yielded higher quality scores, unsupervised monitoring can be acceptable with proper training and protocol adherence.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Digital Health
Background:
- The COVID-19 pandemic accelerated the adoption of home spirometry for monitoring pediatric respiratory conditions.
- Accurate spirometry is crucial for managing conditions like cystic fibrosis.
- Ensuring the technical quality of home-based spirometry is essential for reliable data.
Purpose of the Study:
- To evaluate if remote supervision by a physiologist enhances the technical quality of home spirometry in children.
- To determine the impact of remote supervision on the failure rate of spirometry maneuvers in pediatric patients.
Main Methods:
- Children with cystic fibrosis were randomized to supervised or unsupervised home spirometry using NuvoAir devices.
- Spirometry was conducted every two weeks for 12 weeks.
- Tests were graded using a quality factor (QF) system (A-D, Fail) based on American Thoracic Society/European Respiratory Society standards, with QF A as the primary outcome.
Main Results:
- Significantly more supervised tests achieved QF A (89%) compared to unsupervised tests (74%; p < 0.001).
- The proportion of tests achieving acceptable quality (QF A-C) was high in both groups (99% vs. 95%).
- Observed spirometry declines were primarily clinical, not technical, and patient/family feedback was positive for both groups.
Conclusions:
- Remote supervision by a physiologist is recommended for optimal home spirometry quality in children.
- Acceptable spirometry results can be achieved without direct supervision if adequate training and monitoring protocols are in place.
- Home spirometry is a feasible and well-received monitoring tool for pediatric respiratory conditions.
Introduction:
The coronavirus disease 2019 (COVID-19) pandemic has accelerated the move towards home spirometry monitoring, including in children. The aim of this study is to determine whether the remote supervision of spirometry by a physiologist improves the technical quality and failure rate of the maneuvers.
Method:
Children with cystic fibrosis who had been provided with NuvoAir home spirometers were randomly allocated to either supervised or unsupervised home spirometry following a detailed training session. Home spirometry was performed every 2 weeks for 12 weeks. Tests were assigned a quality factor (QF) using our laboratory grading system as per American Thoracic Society/European Respiratory Society standards, with tests marked from A to D, or Fail. In our laboratory, we aim for QF A in all spirometry tests, but report results of QF B or C with a cautionary note. QF A was, therefore, the primary outcome, and QF A-C, the secondary outcome.
Results:
Sixty-one patients were enrolled; 166 measurements were obtained in the supervised group, and 153 in the unsupervised group. Significantly more measurements achieved QF A in the supervised compared to unsupervised group (89% vs. 74%; p = <0.001), while proportions reaching Grade A-C were similar (99% vs. 95%; p = 0.1). All significant declines in spirometry results had a clinical rather than technical reason. Family/patient feedback for both arms was very positive.
Conclusion:
These results suggest that home spirometry in children should ideally be remotely supervised by a physiologist, but acceptable results can be obtained if resources do not allow this, provided that training is delivered and results monitored according to our protocol.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
08:00Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Chest Physiotherapy
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Physical Assessment of the Respiratory Tract II: Inspection
Chest Configuration
The chest configuration...